ScholarIQanswers from OpenAlex

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

PaperCitations, authors & open-access status

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines have?

ScholarIQcitation count

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines has 214 citations in the OpenAlex counts ScholarIQ stores.

When was MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines published?

ScholarIQyear

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines has 2013 year in the ScholarIQ index.

What is the open-access status of MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines?

ScholarIQoa status

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines has gold oa status in the ScholarIQ index.

What is the DOI of MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines?

ScholarIQdoi

The DOI for MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines is on the source record.

What is the PMID of MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines?

ScholarIQpmid

The PMID for MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines is on the source record.

What is the OpenAlex record for MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines?

ScholarIQopenalex

The OpenAlex for MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial